PURPOSE: Follistatin may affect lean and fat mass and be implicated in metabolic diseases. We aimed to elucidate physiological predictors of circulating follistatin variation in healthy young humans. PROCEDURES: This was an observational, cross-sectional study with two additional prospective observational arms (circadian, seasonal sub-studies) and one prospective interventional arm (mixed meal sub-study). Healthy, young individuals of both sexes (n=122) were subjected to anthropometric and body composition measurements and their eating and exercise behavior profiles were assessed by validated questionnaires. Sub-groups were subjected to standardized meal ingestion (n=36), day-night rhythm (n=20) and seasonal variation (n=20) studies. Main outcome of the study were circulating follistatin levels. RESULTS: At baseline follistatin levels were correlated with creatinine (r=0.24; p=0.01), creatine phosphokinase (rs=0.22; p=0.02), and with lean body mass (rs=0.19; p=0.04) and were higher in males than females (p=0.004) after adjustment for leptin, which was its major predictor. Follistatin levels showed a circadian (p<0.001), but not a seasonal, variation, and were also affected by the phase of menstrual cycle in females (p=0.034). Follistatin levels were not affected by dietary or exercise habits but levels increased after a standardized meal ingestion (250kcal) (p=0.002). CONCLUSIONS: In healthy young individuals circulating follistatin levels are correlated with muscle mass. Follistatin levels are associated with circulating leptin levels and display a day-night rhythm and a menstrual cycle, but not a seasonal, variation.
PURPOSE:Follistatin may affect lean and fat mass and be implicated in metabolic diseases. We aimed to elucidate physiological predictors of circulating follistatin variation in healthy young humans. PROCEDURES: This was an observational, cross-sectional study with two additional prospective observational arms (circadian, seasonal sub-studies) and one prospective interventional arm (mixed meal sub-study). Healthy, young individuals of both sexes (n=122) were subjected to anthropometric and body composition measurements and their eating and exercise behavior profiles were assessed by validated questionnaires. Sub-groups were subjected to standardized meal ingestion (n=36), day-night rhythm (n=20) and seasonal variation (n=20) studies. Main outcome of the study were circulating follistatin levels. RESULTS: At baseline follistatin levels were correlated with creatinine (r=0.24; p=0.01), creatine phosphokinase (rs=0.22; p=0.02), and with lean body mass (rs=0.19; p=0.04) and were higher in males than females (p=0.004) after adjustment for leptin, which was its major predictor. Follistatin levels showed a circadian (p<0.001), but not a seasonal, variation, and were also affected by the phase of menstrual cycle in females (p=0.034). Follistatin levels were not affected by dietary or exercise habits but levels increased after a standardized meal ingestion (250kcal) (p=0.002). CONCLUSIONS: In healthy young individuals circulating follistatin levels are correlated with muscle mass. Follistatin levels are associated with circulating leptin levels and display a day-night rhythm and a menstrual cycle, but not a seasonal, variation.
Authors: João-Paulo G Camporez; Max C Petersen; Abulizi Abudukadier; Gabriela V Moreira; Michael J Jurczak; Glenn Friedman; Christopher M Haqq; Kitt Falk Petersen; Gerald I Shulman Journal: Proc Natl Acad Sci U S A Date: 2016-02-08 Impact factor: 11.205
Authors: T Fujiwara; Y Sidis; C Welt; G Lambert-Messerlian; J Fox; A Taylor; A Schneyer Journal: J Clin Endocrinol Metab Date: 2001-09 Impact factor: 5.958
Authors: Jakob Hansen; Claus Brandt; Anders R Nielsen; Pernille Hojman; Martin Whitham; Mark A Febbraio; Bente K Pedersen; Peter Plomgaard Journal: Endocrinology Date: 2010-11-10 Impact factor: 4.736
Authors: Jakob S Hansen; Sabine Rutti; Caroline Arous; Jens O Clemmesen; Niels H Secher; Andrea Drescher; Carmen Gonelle-Gispert; Philippe A Halban; Bente K Pedersen; Cora Weigert; Karim Bouzakri; Peter Plomgaard Journal: J Clin Endocrinol Metab Date: 2015-12-10 Impact factor: 5.958
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Arne Yndestad; John Willy Haukeland; Tuva Børresdatter Dahl; Kristian Bjøro; Ivar Prydz Gladhaug; Christ Berge; Jan Kristian Damås; Terese Haaland; Else Marit Løberg; Paul Linnestad; Kåre Birkeland; Zbigniew Konopski; Bente Halvorsen; Rolf Kristian Berge; Pål Aukrust Journal: Am J Gastroenterol Date: 2009-06-16 Impact factor: 10.864
Authors: Laurent Maïmoun; Denis Mariano-Goulart; Helena Huguet; Eric Renard; Patrick Lefebvre; Marie-Christine Picot; Anne-Marie Dupuy; Jean-Paul Cristol; Philippe Courtet; Vincent Boudousq; Antoine Avignon; Sébastien Guillaume; Ariane Sultan Journal: Endocr Connect Date: 2022-05-10 Impact factor: 3.221
Authors: L M Turcotte; T E DeFor; L F Newell; C S Cutler; M R Verneris; J Wu; A Howard; M L MacMillan; J H Antin; G M Vercellotti; Ane Slungaard; B R Blazar; D J Weisdorf; A Panoskaltsis-Mortari; S G Holtan Journal: Bone Marrow Transplant Date: 2017-10-23 Impact factor: 5.483